Isolation of Phospholipase A2 from Agkistrodon bilineatus Venom [PDF]
Johnson, Bob D. +2 more
core +2 more sources
Hydrophilic interaction liquid chromatography method development and validation for the assay of HEPES zwitterionic buffer [PDF]
Bracke, Nathalie +5 more
core +2 more sources
Decoding the Metabolic Signatures of Neurodegeneration Diseases: Advances in Mass Spectrometry-Based Metabolomics. [PDF]
Hakim MA, Li L.
europepmc +1 more source
Impact of Lactose Phosphate Impurities on Lactose Crystallization: Deionization as Effective Pretreatment. [PDF]
Trespi S, Mazzotti M.
europepmc +1 more source
Isolation and partial characterization of antimicrobial peptide-enriched fractions from Parabacteroides distasonis. [PDF]
Oliveira AGG +6 more
europepmc +1 more source
Proteoform-Resolved Interaction Studies of Plasminogen by CZE-MS and SEC-MS Under Near-Native Conditions. [PDF]
Neusüß C +4 more
europepmc +1 more source
Conserved Enzymatic Peptides in <i>Bitis arietans</i> Venom Revealed by Comparative Proteomics: Implications for Cross-Reactive Antibody Targeting. [PDF]
Godoi KS +4 more
europepmc +1 more source
Influence of Membrane Ion Sorption on Ammonium Transport in Donnan Dialysis with Cation Exchange Membranes. [PDF]
Tang H, Yang K, Qin M.
europepmc +1 more source
A Synergistic Inhibitor Development Strategy Against Human UDP‐Galactose‐4‐Epimerase
The epimerase GalE is crucial for the biosynthesis of cancer‐relevant O‐GalNAc glycans. Here, we employ orthogonal, structurally enabled small molecule fragment screens to yield both covalent and non‐covalent inhibitors against GalE within no more than 22 elaborated compounds.
William M. Browne +22 more
wiley +1 more source
Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges. [PDF]
Kumar S +6 more
europepmc +1 more source

